Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 12;9(8):2611.
doi: 10.3390/jcm9082611.

Cutaneous Manifestations in Pancreatic Diseases-A Review

Affiliations
Review

Cutaneous Manifestations in Pancreatic Diseases-A Review

Raluca Miulescu et al. J Clin Med. .

Abstract

Pancreatic pathology, comprising acute and chronic pancreatitis, autoimmune pancreatitis and pancreatic neoplasms, primarily presents with gastrointestinal symptoms and signs; however, it is well recognized that it can also associate a wide range of extra-digestive features. Among these systemic manifestations, cutaneous involvement plays an important role both as a diagnostic clue for the pancreatic disease itself and serving as a prognostic factor for the severity of the condition. Recognition of these cutaneous signs is, however, far from being satisfactory, all the more as some of them are relatively rare. In the current review, we discuss skin involvement in pancreatic diseases, referring to pancreatic panniculitis, cutaneous hemorrhagic manifestations, skin metastasis, acanthosis nigricans, livedo reticularis, necrolytic migratory erythema and cutaneous fistula. We highlight the clinical characteristics, treatment and prognostic value of these lesions. Better awareness among medical specialties other than dermatology is needed for detection of the skin clues associated with pancreatic pathology.

Keywords: acanthosis nigricans; acute pancreatitis; chronic pancreatitis; cutaneous; pancreatic cancer; pancreatic panniculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Lévy P., Domínguez-Muñoz E., Imrie C., Löhr J.-M., Maisonneuve P. Epidemiology of chronic pancreatitis: Burden of the disease and consequences. United Eur. Gastroenterol. J. 2014;2:345–354. doi: 10.1177/2050640614548208. - DOI - PMC - PubMed
    1. Mohammadian-Hafshejani A. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2019;4:934–947. doi: 10.1016/S2468-1253(19)30347-4. - DOI - PMC - PubMed
    1. Szentesi A., Tóth E., Bálint E., Fanczal J., Madácsy T., Laczkó D., Ignáth I., Balazs A., Pallagi P., Maleth J., et al. Analysis of Research Activity in Gastroenterology: Pancreatitis Is in Real Danger. PLoS ONE. 2016;11:e0165244. doi: 10.1371/journal.pone.0165244. - DOI - PMC - PubMed
    1. Bonafé J.M., Álvarez J.C., Martín L.S., Alzamora M.P., López E.F., de Unamuno Pérez P. Signos cutáneos en enfermedades pancreáticas. Med. Cutánea Ibero Lat. Am. 2011;39:41–49.
    1. Pinte L., Balaban D.V., Baicus C., Jinga M. Non-alcoholic fatty pancreas disease—Practices for clinicians. Rom. J. Intern. Med. 2019;57:209–219. doi: 10.2478/rjim-2019-0005. - DOI - PubMed